MPM BioVentures 2014, L.P., Former 10% Owner at Harpoon Therapeutics, holds 4.38M shares in Entrada Therapeutics Inc (Ticker: TRDA), holds 0.00 shares in TCR2 Therapeutics (Ticker: TCRR), holds 2.74M shares in iTeos Therapeutics (Ticker: ITOS). Most recently, MPM BioVentures 2014, L.P. Sold ― shares of Entrada Therapeutics Inc on Dec 12, 2024 for an estimated value of 917.11K.
What was MPM BioVentures 2014, L.P.’s latest transaction?
MPM BioVentures 2014, L.P. latest transaction was an Informative Sell of $917.11K.
What was MPM BioVentures 2014, L.P.'s most profitable transaction?
MPM BioVentures 2014, L.P.’s most profitable transaction was an Informative Sell of ITOS stock on January 6, 2022. The return on the trade was 56.50%.
What is MPM BioVentures 2014, L.P.'s role in Harpoon Therapeutics?
MPM BioVentures 2014, L.P.'s role in Harpoon Therapeutics is Former 10% Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.